Sanofi India Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 16,503 shares,. Its Average Traded Price (ATP) is ₹3025.16, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹3047.00.
Sanofi India has an upper circuit limit of ₹3629.00 and a lower circuit limit of ₹2419.40. The total value traded stands at ₹4.99 CR, and the delivery percentage for the day is 56.53%.
The stock is currently traded with a market lot size of 1. Sanofi India also offers a dividend yield of 4.07%.
Sanofi India Share Price Chart
Sanofi India Share Key Metrics
Volume
16503.00
Market Cap
7017.43 CR
LTQ@LTP
1@3047.00
ATP
3025.16
Var Margin
12.5 %
Circuit Range
2419.4-3629
Delivery %
56.53 %
Value
4.99 CR
ASM/GSM
No
Market Lot
1
Sanofi India Resistance and Support
Pivot 3036.67
Resistance
First Resistance
3056.54
Second Resistance
3088.87
Third Resistance
3108.74
Support
First Support
3004.34
Second Support
2984.47
Third Support
2952.14
Sanofi India Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Sanofi India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-04 | Quarterly Results |
| 2026-04-28 | Quarterly Results |
| 2026-02-25 | Quarterly Results & Interim Dividend |
| 2025-10-29 | Quarterly Results & Interim Dividend |
| 2025-07-31 | Quarterly Results |
| 2025-05-14 | Quarterly Results |
| 2025-02-27 | Audited Results & Final Dividend |
| 2024-11-07 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-04-22 | 2026-04-22 | View More |
Sanofi India News
Sanofi India Ltd - 500674 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
Sanofi Healthcare India acquired a 15.20% stake (35 lakh shares) in Sanofi India from Hoechst GmbH at Rs.3,052 per share. This transaction was an inter-se transfer within the promoter group, keeping the total promoter holding unchanged.
Sep 28 2026 15:43:51
Sanofi India Ltd - 500674 - Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
Sanofi Healthcare India Pvt Ltd acquired a 15.20% stake in Sanofi India for Rs. 1,068.2 crores on September 24, 2026. The transaction was an inter-se transfer among promoters executed through a block deal.
Sep 28 2026 13:29:58
Sanofi India Ltd - 500674 - Disclosure Under Regulation 7(2)(B) Of The SEBI (Prohibition Of Insider Trading) Regulations, 2015
Promoter Hoechst GmbH transferred 35 lakh shares (approx 15.2% stake) to Sanofi Healthcare India Private Limited via an inter-se block deal. The transaction is valued at Rs.1,068.20 crores and does not impact the total promoter group holding.
Sep 28 2026 13:25:31
Sanofi India Ltd - 500674 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Sanofi Healthcare India Private Limited acquired 3.5 million equity shares from Hoechst GmbH. Both entities are members of the promoter group, making it an inter-se transfer via block deal, with no change to the overall promoter group shareholding.
Sep 25 2026 14:51:22
Sanofi India Ltd - 500674 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Sanofi Healthcare India, part of the promoter group, acquired 3.5 million equity shares (15.20% stake) of Sanofi India from Hoechst GmbH. This was an inter-se transfer within the promoter group via a block deal on September 24, 2026.
Sep 25 2026 13:37:23
Sanofi India Ltd - 500674 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Hoechst GmbH, part of Sanofi India's promoter group, sold 3.5 million shares (15.20% stake) to another promoter group entity, Sanofi Healthcare India Private Limited, through a block deal. This inter-se transfer maintains the overall promoter shareholding at 60.40%.
Sep 25 2026 13:32:28
Sanofi India Ltd - 500674 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011
Sanofi Healthcare India Private Limited, a promoter group entity, will acquire up to 3,500,000 equity shares, constituting 15.20% stake in Sanofi, from Hoechst GmbH, another promoter. This is an internal transfer among promoter group members, scheduled on or after September 24, 2026.
Sep 18 2026 14:35:03
Sanofi India Ltd - 500674 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Sanofi's petition to quash criminal proceedings, which relate to alleged conspiracy in pharmaceutical supplies to BARC between 2012-2015, was dismissed by the Supreme Court on September 7, 2026. The company is assessing the judgment and formulating its litigation strategy, with no current penalties or operational restrictions.
Sep 08 2026 16:46:50
Sanofi India Management
| Name | Position |
|---|---|
| Aditya Narayan | Chairman |
| Rahul Bhatnagar | Chairman |
Sanofi India Similar Stocks
Procter & Gamble Health Ltd.
5306.00
6.00 (0.11%)
Jupiter Life Line Hospitals Ltd.
253.85
-0.05 (0.02%)
Bliss GVS Pharma Ltd.
676.45
11.65 (1.75%)
Symbiotec Pharmalab Ltd.
1149.50
-20.20 (1.73%)
Innova Captab Ltd.
1141.80
-3.60 (0.31%)
Nephrocare Health Services Ltd.
634.55
-3.10 (0.49%)
Kovai Medical Center & Hospital Ltd.
5936.00
-27.00 (0.45%)
Morepen Laboratories Ltd.
143.96
8.67 (6.41%)
Senores Pharmaceuticals Ltd.
1388.60
67.40 (5.10%)
Orchid Pharma Ltd.
1006.55
40.65 (4.21%)
Sanofi India FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in SANOFI
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC